Instead, they focus on finding a treatment approach that is safe and tailored to your unique situation
Garca-Closas, M
In July 2024, a study published in JAMA Ophthalmology found that patients using semaglutide, which is the active ingredient in both Ozempic and Wegovy, faced a significantly higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION)
Zhang Y, Guo Q, Fang X, et al
"We expect that if we address the obesity issue in this country, then in theory, it should create savings down the road for cardiovascular conditions, liver conditions and kidney conditions," he said
Your care is personalized, provider-reviewed, and designed to support steady progress rather than extreme restrictions